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Abstract. Accurately identifying and targeting the human reservoir ofmalaria parasitemia is critical formalaria control,
and requires a reliable and sensitive diagnostic method. Loop-mediated isothermal ampliﬁcation (LAMP) is increasingly
used todiagnose submicroscopic parasitemia. Althoughmost published studies report the sensitivity of LAMPcompared
with nested polymerase chain reaction (PCR) as ³ 80%, they have failed to use a consistent, sensitive diagnostic as
a comparator. We used cross-sectional samples from children and adults in Tororo, Uganda, a region with high but
declining transmission due to indoor residual spraying, to characterize the sensitivity and speciﬁcity of pan-Plasmodium
LAMP for detecting submicroscopic infections. We compared LAMP results targeting a mitochondrial DNA sequence
conserved in all Plasmodium species, performed on DNA extracted from dried blood spots, to those of a gold standard
quantitative PCR assay targeting the var gene acidic terminal sequence of Plasmodium falciparum (varATS qPCR),
performed on DNA extracted from 200 mL of whole blood. Using LAMP and varATS qPCR increased the detection of
parasitemia 2- to 5-fold, compared with microscopy. Amongmicroscopy-negative samples, the sensitivity of LAMPwas
81.5% for detecting infection ³ 1parasites/mL.However, lowdensity infectionswere common, andLAMP failed to identify
more than half of all infections diagnosed by varATS qPCR, performing with an overall sensitivity of 44.7% for detecting
submicroscopic infections ³ 0.01 parasites/mL. Thus, although the LAMP assay is more sensitive than microscopy, it
missed a signiﬁcant portion of the submicroscopic reservoir. These ﬁndings have important implications for malaria
control, particularly in settings where low-density infections predominate.
INTRODUCTION
Ambitious goals formalaria control and elimination highlight
the need for a reliable, sensitive, and cost-effective method of
detecting malaria infection, including the large proportion of
asymptomatic and low-density infections that are not de-
tected by microscopy. Loop-mediated isothermal ampliﬁca-
tion (LAMP) is a simple method for diagnosing submicroscopic
malaria parasitemia, and it has been validated in both high-
and low-transmission settings.1–4 DNA can be extracted
from dried blood spots (DBSs), reagents speciﬁc for am-
pliﬁcation of Plasmodium species mitochondrial DNA are
vacuum dried into premade kits, and nucleic acid ampliﬁ-
cation can be performed without a thermal cycler, making
LAMP more accessible than polymerase chain reaction
(PCR) in ﬁeld settings.
Previous studies have reported LAMP sensitivity for the
detection of Plasmodium species infection ranging from 76%
to 98%, compared with other nucleic acid ampliﬁcation-
based techniques,1–5 with a lower limit of detection of
1–5parasites/μL.6Studies havegenerally usedDNAextracted
fromDBS, and have included comparisons of pan-Plasmodium
LAMP, targeting a mitochondrial DNA sequence that is
conserved in allPlasmodium species,7 to either nested or real-
time PCR targeting the cytochrome b gene (Cyt b) of the four
major humanPlasmodium species, or to nestedPCR targeting
the Plasmodium falciparum 18S ribosomal RNA (rRNA) gene,
with a range of sensitivities mostly > 80%.1,2,8–10 Un-
fortunately, the lack of a consistent comparator limits our
ability to deﬁne the operating characteristics of LAMP, and by
extension, to precisely deﬁne the parasite reservoir at a par-
ticular location. This is problematic for areas where low-
density infections, including infections that are missed by
microscopy or immunochromatographic rapid diagnostic
tests, make signiﬁcant contributions to transmission.11,12
Nested PCR is quickly being replaced as the standard di-
agnostic for identifying submicroscopic infections, and more
sensitive DNA-based methodologies using larger sample
volumes and improved targets have uncovered a pool of
ultralow-density infections, with parasite densities < 1
parasite/μL.13 The availability of a quantitative PCR method
targeting the vargene acidic terminal sequence ofP. falciparum
(varATS qPCR) offers the opportunity for a “gold standard”
comparator for LAMP. The reported lower limit of detection
of the varATS qPCR assay is 0.03–0.15 parasites/μL blood,
10-foldmore sensitive than standard 18S rRNA qPCR.14 In this
study,weused samples from repeated cross-sectional surveys
in an Ugandan cohort to compare a ﬁeld-applicable LAMP
method, pan-Plasmodium LAMP, performed using DNA
extracted fromDBSs, to a highly sensitive varATS qPCRassay,
performedon200μLofwholeblood. LAMP iscurrently awidely
used diagnostic for identifying submicroscopic parasitemia.
Wewere interested in theperformanceofLAMP,asused in real-
world ﬁeld settings, for diagnosing malaria infection in patients
who were microscopy negative.
MATERIALS AND METHODS
The study took place in Nagongera subcounty, Tororo
District, Uganda, near the Kenyan border. In this area, malaria
transmission has been high and perennial,15 with annual
entomological inoculation rates of > 300 person/year in
2011–2012,16 but transmission intensity declined dramatically
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after initiation of indoor residual spraying (IRS) of insecticides
in December 2014.17 Samples for this study were obtained
from repeated cross-sectional surveys in a cohort of children
(age 0.5–10 years) and adults (age ³ 18) between May and
December 2015, coinciding with a second and third round of
IRS that took place in the district June to July 2015 and
November to December 2015. Cohort enrollment, cross-
sectional surveys, and clinical care have been described
previously.16,18 Brieﬂy, participants presented to the clinic for
routine visits every 90 days, meaning most participants had
two routine visits in the 8-month study period. At each routine
visit, a blood smear, DBS, and 200 μL aliquot of blood were
collected. VarATS qPCR from whole blood was performed on
all samples. LAMP fromDBSwas performed on samples from
patients who were microscopy negative. Participants were
invited to visit the clinic any time they were ill, andmicroscopy
was performed when there was a reported or documented
fever. Patients with temperature greater than 38C and posi-
tive microscopy were diagnosed with clinical malaria, and
treated with standard dosing of artemether-lumefantrine.
Participants with asymptomatic parasitemia were not
provided antimalarial therapy, in accordance with local
standards.
Thick smears were prepared with 2% Giemsa and micros-
copy was performed by experienced laboratory technicians.
Slides were double read by two microscopists; a third mi-
croscopist resolved discrepancies. Microscopy was not used
for Plasmodium species determination. DBS specimens were
prepared by spotting approximately 30 μL of blood onto ﬁlter
paper, drying completely, and storing at room temperature.
DNA was extracted for LAMP using Chelex, as previously
described,19 yielding 200mLofDNAextractionproduct. LAMP
was performed using Eiken LoopampTM Malaria Pan De-
tection Kit (Eiken Chemical, Tokyo, Japan) reaction tubes and
15 mL of extracted DNA, per manufacturer’s guidelines. The
LAMP primer set targets a mitochondrial DNA sequence that
is conserved in all four major human malaria species.7 Al-
though we were primarily interested in P. falciparum infec-
tions, which make up the majority of infections in our setting,
we used pan-Plasmodium LAMP kits (Eiken Chemical) be-
cause they are readily available for purchase and widely used
worldwide. LAMP reactions were assessed based on visual
detection of ﬂuorescence under an ultraviolet lamp. Each
batch of 48 LAMP reactions included three controls with
known P. falciparum densities (10, 1, and 0 parasite/mL), as
well as one positive and one negative control from the
Eiken kit.
For our gold standard comparator, DNAwas extracted from
200 mL of whole blood samples and controls using QIAamp
DNA Blood Mini Kits (Qiagen, Hilden, Germany), yielding 200
mL of DNA extraction product. Molecular detection and
quantiﬁcation of P. falciparum was performed with quantita-
tive PCR targeting the varATS region on 5 mL of extraction
product, using previously published methods.14 Parasite
density was quantiﬁed by comparison to a standard curve of
cultured parasites. Cultured W2 parasites were synchronized
to ring stage,with initial density determinedby ﬂowcytometry,
thennormalized to amaximumconcentration of 104 parasites/
μL, and serially diluted in whole blood from 104 to 10−2 para-
sites/mL. All samples and controls were quantiﬁed in du-
plicate and averaged, with samples having a parasite
density greater than 10−1 parasites/mL and a Ct coefﬁcient of
variation > 0.05 repeated. For all samples that were LAMP
positive andvarATSqPCRnegative, nestedPCRamplifying the
Cytb, using5μL templateDNAwasperformedusingpreviously
published methods.20 Species determination was based on
AluI restriction digestion of the ampliﬁed Cyt b, as previously
described.21 All qPCR was done on an Applied Biosystems
(Foster City, CA) StepOnePlus Real-Time PCR System.
Datawere analyzed using STATA (version 13; STATACorp.,
College Station, TX). Malaria incidence was deﬁned as the
number of episodes of clinical malaria (temperature > 38C
and patent parasitemia, as previously deﬁned in this cohort)16
detected by passive surveillance per person-year of obser-
vation. Parasite prevalence was calculated as follows: 1) mi-
croscopic parasitemia, deﬁned as the proportion of routine
visits with a positive microscopy, with or without fever, 2) mi-
croscopic or LAMP parasitemia, deﬁned as the proportion
of routine visits with either positive microscopy or a positive
LAMP reaction, and 3) microscopic or varATS parasitemia,
deﬁned as the proportion of routine visits with either positive
microscopy or positive varATS qPCR. Distribution of parasite
densities refers to the proportion of samples with parasite
density by varATS qPCR in a given range, among all samples
with varATS qPCR results ³ 0.01 parasites/mL. Mean parasite
densities for different risk categories were estimated by cal-
culating the geometricmean of all samples in a given category
with a varATS qPCR result ³ 0.01 parasites/mL. The sensitivity
and speciﬁcity of LAMP for detecting submicroscopic in-
fection was determined based on results of 554 samples that
were microscopy negative, in which both LAMP and varATS
qPCR testing was performed.
RESULTS
Study participants, parasite prevalence, and parasite
densities.Characteristics of study participants are presented
in Table 1. During the 8 months of observation, 232 child
and 78 adult participants made 675 routine (every 90 days)
visits to the study clinic. As expected, the majority of epi-
sodes of malaria diagnosed during the study period, either at
or between routine visits, occurred in children, with an in-
cidence rate of 0.24 episodes/person-year in children and
0.02 episodes/person-year in adults. Using microscopy, the
TABLE 1
Study characteristics
Children Adult
Number of participants 232 78
Mean age, years (SD) 6.5 (2.6) 42.0 (12.7)
Number female (%) 106 (46) 71 (91)
Number of routine visits 492 183
Incidence of malaria during
study period (episodes per person year)
0.24 0.02
Malaria parasite prevalence
By microscopy 21.7% 7.7%
By microscopy or LAMP 40.7% 26.8%
By microscopy or varATS qPCR 51.2% 42.1%
Distribution of parasite densities
by varATS qPCR*
Parasite density ³ 0.01 to < 0.1 25.5% 31.2%
Parasite density ³ 0.1 to < 1 12.8% 18.1%
Parasite density ³ 1 61.7% 50.7%
LAMP = loop-mediated isothermal ampliﬁcation; qPCR = quantitative polymerase chain
reaction;SD=standarddeviation; varATS= vargeneacidic terminal sequenceofPlasmodium
falciparum.
* Parasite density in parasites/mL.
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prevalence of parasitemia at routine visits was 21.7% in chil-
dren and 7.7% in adults. When microscopy was used in
conjunction with either LAMP or varATS qPCR, parasite
prevalence was 2- to 5-fold higher than with microscopy
alone, with a prevalence of 40.7% or 51.2% in children, and
26.8%or42.1% inadults, respectively (P<0.01 for all pairwise
comparisons within age groups). When prevalence based on
LAMP or varATS qPCR was directly compared, differences
were more pronounced among adults than children, with the
useof varATSqPCR increasingprevalenceby>50% inadults,
compared with 26% in children. The distribution of parasite
densities by varATS qPCR differed between adults and chil-
dren. Among patients whowere varATS qPCRpositive, adults
were more likely to have a parasite density < 1 parasite/mL,
compared with children (P = 0.04). However, roughly 40% of
childrenwith detectable parasitemia hadaparasite density < 1
parasite/mL, indicating that in this setting of declining trans-
mission, low parasite density infections were common in both
adults and children.
Parasite prevalence based on varATS qPCR, stratiﬁed
by LAMP and microscopy results. Results from all 675
routine visits were stratiﬁed by LAMP andmicroscopy results,
allowing for determination of parasite prevalence by the
varATS qPCR assay among different risk groups (Table 2).
Parasite prevalence was 27.0% among LAMP-negative indi-
viduals, with a geometric mean parasite density in these in-
dividuals of 0.11 parasites/mL. Among individuals that were
LAMP positive but microscopy negative, parasite prevalence
by varATS qPCR was 72.7%, with a mean parasite density of
5.70 parasites/mL. Thirty-ﬁve samples, from 30 children and
5 adults, were LAMP positive but varATS qPCR negative.
Because varATS qPCR is speciﬁc for P. falciparum infection,
these samples were tested for the presence of another Plas-
modium species using Cyt b nested PCR. Of these 35 sam-
ples, 15 (43%) were positive for P. ovale, three (9%) were
positive forP. falciparum, three (9%) hadmixed infectionswith
P. falciparum plus either P. vivax or P. malariae, one (2%) was
positive by Cyt b but failed speciation due to insufﬁcient DNA,
and 13 (37%) were Cyt b negative. Among samples that were
microscopypositive, parasiteprevalencewas>90%byvarATS
qPCR. Cyt b PCR was also performed on three samples
with microscopic parasite densities above 1,000 parasite/mL
butnegativevarATSqPCR,andyielded1/3samplespositive for
P. falciparum, 1/3 with mixed P. falciparum and P. vivax in-
fection, and 1/3 Cyt b negative.
Sensitivity of LAMP assay. Of 675 visits at which varATS
qPCRwasperformed, 554 hadnegativemicroscopy, and thus
had associated LAMP tests allowing for direct comparison of
LAMP and varATS qPCR (Table 3). The 15 infections pre-
viously determined to be P. ovale were excluded from this
comparison. Among all microscopy-negative patients with
parasitemiadetectable by varATSqPCR (limit of detection³ 0.01
parasites/mL), LAMP had a sensitivity of only 44.7%, with a
speciﬁcity of 94.0%. For the lowest parasite densities de-
tected by varATS qPCR (0.01–0.1 parasites/mL), LAMP de-
tected approximately one in 10 infections. Compared with
varATS qPCR reactions with parasite density ³ 1 parasites/mL
among microscopy-negative patients, LAMP performed with
a sensitivity of 81.5%. Sensitivity was not affected by recent
treatment of malaria, and was less than 50% overall in both
children and adults.
DISCUSSION
We compared a ﬁeld-applicable method for diagnosing
submicroscopic parasitemia to a more sensitive gold stan-
dard, using repeated cross-sectional surveys from a cohort in
Uganda. Consistent with our prior ﬁndings,18 LAMP increased
the detection of parasitemia, compared with microscopy, by
more than 2-fold in both children and adults. However, our
results indicate that LAMP may miss a substantial portion of
the parasite reservoir, particularly when considering asymp-
tomatic, ultralow-density infections. In our study, low-density
infections were common in both children and adults, and
LAMP detected less than half of all submicroscopic infections
identiﬁed by varATS qPCR.
Similar to results from previous reports,1–3,9 in our study
LAMP performed with ³ 80% sensitivity and speciﬁcity, com-
paredwithqPCR,whenusingaparasitedensity of³ 1parasite/μL
as the diagnostic threshold. However, when considering
the lower limit of detection of the varATS qPCR assay, and
thus including ultralow-density infections, LAMP had only
45% sensitivity. This ﬁnding may be particularly relevant in
low-burden areas, where submicroscopic infections make
up a majority of the parasite reservoir.22 Notably in our
study, which took place in an area of high but declining
TABLE 2
Prevalence of parasitemia and mean parasite density, stratiﬁed by
LAMP or microscopy result
Prevalence by varATS
qPCR
Geometric mean parasite density*
(parasites/mL) (95% CI)
LAMP and
microscopy result
LAMP (−) 115/426 (27.0%) 0.11 (0.07–0.17)
Microscopy (−)
LAMP (+) 93/128 (72.7%) 5.70 (3.00–10.8)
Microscopy (−)
Microscopy (+) 70/76 (92.1%) 181.7 (95.8–344.7)
Density by LM <
1,000
Microscopy (+) 42/45 (93.3%) 3884.0 (2,562.4–5,887.2)
Density by LM ³
1,000
CI = conﬁdence interval; LAMP = loop-mediated isothermal ampliﬁcation; qPCR =
qunantitative polymerase chain reaction; varATS = var gene acidic terminal sequence of
Plasmodium falciparum.
* Densities of < 0.01 parasites/mL were considered zero and excluded from estimation of
geometric mean.
TABLE 3
Operating characteristics of LAMP, compared with varATS qPCR, in
microscopy-negative patients*
Sensitivity (%) Speciﬁcity (%)
Stratiﬁed by parasite density (parasites/mL)†
Parasite density, all samples ³ 0.01 93/208 (44.7) 311/331 (94.0)
Parasite density ³ 0.01 to < 0.1 9/83 (10.8) –
Parasite density ³ 0.1 to < 1 18/44 (40.9) –
Parasite density ³ 1 66/81 (81.5) –
Stratiﬁed by recent malaria
No recent malaria episode 80/181 (44.2) 302/322 (94.0)
Malaria episode in past 30 days 13/27 (48.2) 9/9 (100)
Stratiﬁed by age
Child 63/145 (43.5) 210/225 (93.3)
Adult 30/63 (47.6) 101/106 (95.3)
* Sensitivity and speciﬁcity calculated in microscopy-negative patients, excluding those
with non-falciparum infections (N = 539).
†Parasite density in parasites/mL.
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transmission, more than a third of children and nearly half
of adults with detectable infection had a parasite density < 1
parasite/μL.
When varATS qPCR results were stratiﬁed based on LAMP,
more than a quarter of LAMP-negative samples had detect-
able parasitemia by varATS qPCR, and these infections had a
mean parasite density of < 1 parasite/μL. The use of DNA
extracted from a relatively large volume of whole blood, cou-
pled with an extremely sensitive qPCR assay, allowed us to
detect infections that would otherwise have been missed.
Although the majority of infections missed by LAMP in this
study were ultralow density, these ﬁndings may have impor-
tant implications for malaria transmission. At present, there is
debate as to what degree submicroscopic infections con-
tribute to malaria transmission; this contribution is probably
mitigated whether the setting is high or low burden, and by
whether the infection is predominately asexual or sexual
parasitemia. Submicroscopic gametocyte carriage is clearly
relevant to transmission, with evidence from mosquito-
feeding studies suggesting that individuals can infect
mosquitos in the absence of microscopically detectable
gametocytes23,24; however, individuals with asexual para-
sitemia and no gametocytes detectable by nucleic acid
sequence-based ampliﬁcation are also capable of infecting
mosquitoes.12 In a low-endemicity setting, submicroscopic
gametocyte infections were recently shown to be relatively
unimportant to malaria transmission25; however, in higher
endemicity settings, submicroscopic infection may account
for a large proportion of the transmission cycle.11,12 Thus,
identifying carriers of low-density infection, which can persist
for months,26 may be important when programmatic goals
shift from reducing morbidity and mortality to controlling
malaria transmission and moving toward malaria elimination.
We identiﬁed 35 samples that were positive by LAMP, but
negative by varATS qPCR. When nested Cyt b PCR was
performed, the majority of these samples were positive for
P. ovale or mixed infection with P. falciparum plus either
P. vivax or P. malariae, adding to existing evidence that non-
falciparum species play a role in the epidemiology of this
region.27–30 However,more than a third of these sampleswere
Cyt b negative. Previous studies have also reported LAMP-
positive samples with infections that were not identiﬁed by
PCR,2,3 which may be due to the large number of primers per
target in LAMP and increased likelihood of primer–primer in-
teractions, leading to false-positive results.
It is notable that the cross-sectional surveys described here
took place in the context of a major IRS campaign, which led
to a marked reduction in transmission intensity.17 Although
spraying with the carbamate bendiocarb took place in the
district 6 months before sample collection, and again during
the course of these cross-sectional surveys, with malaria in-
cidence dropping dramatically, we describe a signiﬁcant
submicroscopic reservoir during and immediately after IRS. A
high proportion of infections were of low density, with one in
10 participants having extremely low-density infections of
0.01–0.1 parasite/mL. Although further studies are needed to
better characterize this reservoir, our results suggest that in
addition to impacts onmalaria morbidity and slide positivity in
Uganda,31,32 IRS may shift the distribution of parasite densi-
ties to lower density infections. We hypothesize that in a high
endemicity setting experiencing a rapid decline in trans-
mission, a greater proportion of infections detected may be
low density, due to controlled infections in a population that
retains natural immunity.
A better understanding of the epidemiology of malaria para-
sitemia is critical to best allocating resources and assessing
the impact of malaria control efforts. LAMP offers markedly
improved diagnostic sensitivity comparedwithmicroscopy and
available rapid diagnostic tests, and it is usable in ﬁeld settings,
but it may miss a signiﬁcant portion of the submicroscopic
reservoir. We found that ultralow-density infections were com-
mon in both children and adults in a high-transmission setting
that recently underwent an IRS campaign, and that LAMP
missed approximately half of detectable submicroscopic in-
fections. As malaria control improves and we move toward
elimination in traditionally high-burden areas, it is important to
remember that all infections, including those missed by current
diagnostics, are potential drivers of transmission. Our ﬁndings
highlight the need to consider the limitations of our diagnostic
tests in the setting of declining transmission.
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